Your browser doesn't support javascript.
loading
Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial.
Shen, Kai-Ni; Fu, Wei-Jun; Wu, Yu; Dong, Yu-Jun; Huang, Zhong-Xia; Wei, Yong-Qiang; Li, Chun-Rui; Sun, Chun-Yan; Chen, Ye; Miao, Hui-Lei; Zhang, Yue-Lun; Cao, Xin-Xin; Zhou, Dao-Bin; Li, Jian.
Afiliação
  • Shen KN; Department of Hematology (K.S., H.M., X.C., D.Z., J.L.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Fu WJ; Department of Hematology, Changzheng Hospital, The Second Military Medical University, Shanghai, People's Republic of China (W.F.).
  • Wu Y; Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, People's Republic of China (Y.W.).
  • Dong YJ; Department of Hematology, Peking University First Hospital, Beijing, People's Republic of China (Y.D.).
  • Huang ZX; Multiple Myeloma Medical Center of Beijing, Department of Hematology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, People's Republic of China (Z.H.).
  • Wei YQ; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China (Y.W.).
  • Li CR; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China (C.L.).
  • Sun CY; Institute of Hematology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China (C.S.).
  • Chen Y; Department of Hematology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China (Y.C.).
  • Miao HL; Department of Hematology (K.S., H.M., X.C., D.Z., J.L.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Zhang YL; Medical Research Center (Y.Z.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Cao XX; Department of Hematology (K.S., H.M., X.C., D.Z., J.L.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Zhou DB; Department of Hematology (K.S., H.M., X.C., D.Z., J.L.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Li J; Department of Hematology (K.S., H.M., X.C., D.Z., J.L.), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Circulation ; 145(1): 8-17, 2022 01 04.
Article em En | MEDLINE | ID: mdl-34503349
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Doxiciclina / Ciclofosfamida / Bortezomib / Amiloidose Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Doxiciclina / Ciclofosfamida / Bortezomib / Amiloidose Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2022 Tipo de documento: Article